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Abstracts / International Journal of Surgery 36 (2016) S31eS132 S37Conclusions: In this audit, swab results did not alter any patient's treat-
ment and nearly all reports were issued after the patient had been dis-
charged. Recurrent abscesses do not appear to be linked to initial swab
results.http://dx.doi.org/10.1016/j.ijsu.2016.08.033
0705: ADHESIVE SMALL BOWEL OBSTRUCTION: TRENDS IN INCIDENCE,
MANAGEMENT AND OUTCOMES OVER 15 YEARS
M. Abdelhalim 1,*, R. McLean 2, I. McCallum 1. 1 Sunderland Royal Hospital,
Sunderland, UK; 2Queen Elizabeth Hospital, Gateshead, UK.
Aims: Small bowel obstruction in a patient who has previously undergone
abdominal surgery is a common emergency presentation in general sur-
gery. This study describes the changes in incidence, management and
outcomes in adhesive small bowel obstruction (ASBO) over a 15 year
period (2000-2014).
Methods: Data for all emergency admissions under a general surgeon
were collected from regional trust information departments and analysed.
Results: 6,557 cases of ASBO were identiﬁed and divided into 3 time pe-
riods. Requirement for operative management has reduced from 54% to
40% to 29% over the time intervals (p<0.05). Overall, patients requiring
surgery were older than those who improved with conservative man-
agement (61.7 years compared to 56.1 years, p<0.05). There was a signif-
icant reduction in length of stay (17.1 days, 14.9 days, 12.4 days) as well as
inpatient mortality (11%, 8%, 4%) during the study period (p<0.05).
Conclusions: There has been an increase in emergency admissions for
ASBO over time, but operative management is required less often. Con-
servative management is more likely to be successful in younger patients.
Overall outcomes as measured by length of stay and inpatient mortality
improved during the study period. Advances in operative techniques and
preoperative management could account for these positive results.http://dx.doi.org/10.1016/j.ijsu.2016.08.034
0520: SURGICAL MANAGEMENT OF FISTULATING PERIANAL CROHN'S
DISEASE e RESULTS OF A UK SURVEY
M. Lee 1,*, N. Heywood 2, P. Sagar 4, S. Brown 3, N. Fearnhead 5. 1 South
Yorkshire Surgical Research Group, Shefﬁeld, UK; 2Northwest Research
Collaborative, Manchester, UK; 3 Shefﬁeld Teaching Hospitals, Shefﬁeld, UK;
4 Leeds Teaching Hospitals, Leeds, UK; 5Addenbrookes Hospital, Cambridge, UK.
Aim: Fistulating perianal Crohn’s disease (PCD) affects 20-50% of Crohn’s
patients. Despite advances in medical therapy, recurrence is frequent and
there is signiﬁcant impact on quality of life.
Method: A questionnaire was developed to assess current Consultant
Colorectal surgeon practice in PCD and piloted at DDF 2015. The ﬁnal
version of the questionnairewas disseminated through the surgical trainee
research collaboratives. Responses were uploaded onto the REDCAP online
database.
Result: Collaborators from 21 centres collected 107 responses. In the acute
setting, 38% always give antibiotics, with metronidazole preferred (81.5%).
Incision and drainage (30%) or draining seton (35%) are preferred at ﬁrst
operation. Draining seton is preferred at ﬁrst-planned EUA (61%). Cutting
seton (86.1%), excision of tract (60.1%) and ﬁstulotomy (37.9%) are avoided.
IBD MDT was available to 85% of respondents, and 29% routinely discussed
PCD patients. Multimodal therapy is practiced by 92% of respondents.
Preferred ‘deﬁnitive’ procedures were removal of seton (68%), ﬁstulotomy
(52%), mucosal advancement ﬂap (38%) and ﬁstula plug (32%).
Conclusion: A collaborative approach demonstrates wide variation in
practice across UK centres. This information will inform a consensus ex-
ercise for UK practice as well as feasibility for a planned surgical trial.http://dx.doi.org/10.1016/j.ijsu.2016.08.0350888: ACUTE DIVERTICULITIS: RISK OF READMISSION AND EMERGENCY
SURGERY FOLLOWING AN ADMISSION FOR ACUTE DIVERTICULITIS
C. El-Sayed 1,*, S. Radley 2, J. Mytton 2, F. Evison 2, S. Ward 1. 1University
Hospitals Coventry and Warwickshire, West Midlands, UK; 2University
Hospitals Birmingham, West Midlands, UK.
Aim: Diverticular disease is accountable for signiﬁcant morbidity and
mortality. Current guidelines suggest elective resection should be indi-
vidualised to each patient. We aimed to identify risk factors associated
with risk of readmission.
Method: This study was conducted between April 2006 and March 2011
identifying 76,499 patients over the age of 18 with acute diverticulitis who
were followed up for 4 years. Exclusion criteria included previous diag-
nosis of diverticulitis in HES data, colorectal cancer, GI bleed, previous
colectomy, undergone surgery or died on index admission. 65,162 patients
were included in the study.
Result: This is the largest study using HES data in the UK. A mixed effects
logistic regression model was used for analysis. The re-admission rate
equaled 11.55%. 1.16% of patients were readmitted within 30 days. An in-
verse relationship between age and risk of re-admission was found. Fe-
males were 46% more likely to be re-admitted (p <0.001). Complicated
diverticulitis increased the risk of re-admission (OR 1.5 (0.95-1.12)
p<0.001). Alcohol consumption also increased the risk of re-admission (0R
1.26 (1.17-1.35) p-value <0.001).
Conclusions: Risk of re-admission with acute diverticulitis decreases
with older age, male gender and uncomplicated diverticulitis. Elective
surgery should be offered based on the individual’s risk factors for
readmission.http://dx.doi.org/10.1016/j.ijsu.2016.08.036
0437: DEFINING A 3D BIOMIMETIC COLORECTAL TUMOUROID
E. Losif*, K. Stamati, A. Nyga, B. Ramesh, M. Loizidou. University College
London, UK.
Aim: Colorectal cancer is a worldwide healthcare problem. Better under-
standing of pathogenesis and relevant models to study drug action could
improve therapies. There has been an increase in 3D in-vitro models,
however most lack tissue density. We aimed to create and characterize a
3D in-vitro cancer model, comprising cancer and stromal cells in a dense
matrix.
Methods: CRC cells (HT29) and patient ﬁbroblasts (CRC-associated ﬁbro-
blasts-CRF;normal colon ﬁbroblasts-CF) were used. High density com-
pressed tumouroids (9.6%, collagen 3D-cultures) were manufactured by
mixing different ratios of HT29:ﬁbroblasts. The following were measured:
cell viability for establishing seeding density and optimal HT29:ﬁbroblast
ratio; size measurements of cancer spheroids; biomarker (TGFb, VEGF)
expression (ELISA); cell/spheroid morphology (cytokeratin-20, e-cadherin,
vimentin, a-SMA immunoﬂuorescence).
Results: Maximum seeding density for 7-day proliferation was 75,000
cells/(1,3ml)gel. Tumouroids with HT29:CF/CRF ratio(1:2) had signiﬁcantly
increased (p<0.05) metabolic activity. Cells aggregated in spher-
oids(epithelial) and stained for cytokeratin-20 and e-cadherin or distrib-
uted throughout(ﬁbrοblasts) and stained for vimentin (mesenchymal
phenotype). Co-culture spheroid diameter and surface area was signiﬁ-
cantly (p<0.05) higher than HT29 monocultures. Biomarker release was
higher in co-cultures (1:2) compared to HT29 monocultures (P¼0.008) on
day 3.
Conclusions:High density tumouroids provide a biomimetic platform that
resembles the tumor microenvironment, suitable for assessing tumor
growth and potentially therapeutic responses.http://dx.doi.org/10.1016/j.ijsu.2016.08.037
